Monash Ivf Group Ltd (MVF) - Total Assets
Based on the latest financial reports, Monash Ivf Group Ltd (MVF) holds total assets worth AU$512.35 Million AUD (≈ $362.52 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see MVF cash flow conversion for how efficiently the company converts equity into cash flow.
Monash Ivf Group Ltd - Total Assets Trend (2013–2026)
This chart illustrates how Monash Ivf Group Ltd's total assets have evolved over time, based on quarterly financial data. See Monash Ivf Group Ltd (MVF) share price today for real-time trading data and today's change.
Monash Ivf Group Ltd - Asset Composition Analysis
Current Asset Composition (June 2026)
Monash Ivf Group Ltd's total assets of AU$512.35 Million consist of 8.6% current assets and 91.4% non-current assets. Explore MVF net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 1.7% |
| Accounts Receivable | AU$17.62 Million | 3.4% |
| Inventory | AU$10.37 Million | 2.0% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$22.20 Million | 4.3% |
| Goodwill | AU$273.35 Million | 53.4% |
Asset Composition Trend (2013–2026)
This chart illustrates how Monash Ivf Group Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Monash Ivf Group Ltd's current assets represent 8.6% of total assets in 2026, a decrease from 17.4% in 2013.
- Cash Position: Cash and equivalents constituted 1.7% of total assets in 2026, down from 15.3% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 57.0% of total assets, a decrease from 78.0% in 2013.
- Asset Diversification: The largest asset category is goodwill at 53.4% of total assets.
Monash Ivf Group Ltd Competitors by Total Assets
Key competitors of Monash Ivf Group Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
BGI Genomics Co Ltd
SHE:300676
|
China | CN¥11.35 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Wuhan Thalys Med Tech Co Ltd
SHG:603716
|
China | CN¥1.59 Billion |
|
Bcal Diagnostics Ltd
AU:BDX
|
Australia | AU$7.66 Million |
|
Check-Cap Ltd
F:7CC
|
Germany | €7.49 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$16.78 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
Monash Ivf Group Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.67 | 0.68 | 0.55 |
| Quick Ratio | 0.51 | 0.53 | 0.45 |
| Cash Ratio | 0.00 | 0.15 | 0.21 |
| Working Capital | AU$-21.61 Million | AU$-19.73 Million | AU$-18.58 Million |
Monash Ivf Group Ltd - Advanced Valuation Insights
This section examines the relationship between Monash Ivf Group Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.24 |
| Latest Market Cap to Assets Ratio | 0.40 |
| Asset Growth Rate (YoY) | 4.0% |
| Total Assets | AU$512.35 Million |
| Market Capitalization | $206.77 Million USD |
Valuation Analysis
Below Book Valuation: The market values Monash Ivf Group Ltd's assets below their book value (0.40x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Monash Ivf Group Ltd's assets grew by 4.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Monash Ivf Group Ltd (2013–2026)
The table below shows the annual total assets of Monash Ivf Group Ltd from 2013 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-06-30 | AU$512.35 Million ≈ $362.52 Million |
+4.01% |
| 2025-06-30 | AU$492.61 Million ≈ $348.55 Million |
-3.12% |
| 2024-06-30 | AU$508.47 Million ≈ $359.77 Million |
+20.52% |
| 2023-06-30 | AU$421.89 Million ≈ $298.52 Million |
+8.99% |
| 2022-06-30 | AU$387.10 Million ≈ $273.90 Million |
+8.68% |
| 2021-06-30 | AU$356.17 Million ≈ $252.02 Million |
+0.55% |
| 2020-06-30 | AU$354.22 Million ≈ $250.64 Million |
+22.13% |
| 2019-06-30 | AU$290.04 Million ≈ $205.22 Million |
-0.20% |
| 2018-06-30 | AU$290.61 Million ≈ $205.63 Million |
+1.17% |
| 2017-06-30 | AU$287.25 Million ≈ $203.25 Million |
-0.09% |
| 2016-06-30 | AU$287.52 Million ≈ $203.44 Million |
+1.58% |
| 2015-06-30 | AU$283.05 Million ≈ $200.28 Million |
+14.89% |
| 2014-06-30 | AU$246.36 Million ≈ $174.31 Million |
-7.25% |
| 2013-06-30 | AU$265.61 Million ≈ $187.94 Million |
-- |
About Monash Ivf Group Ltd
Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. The company also provides tertiary level prenatal diagnostic, ultrasound, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 a… Read more